Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 15/20 | 0.48 |
| ▸ | PPARG | P37231 | 10/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | BCL9 | O00512 | 1/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.37 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.37 |
| ▸ | MCTS1 | Q9ULC4 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6512808 | 0.92 | PPARA (0.48) | PPARAPPARGPPARD | |
| SCHEMBL6511378 | 0.86 | PPARA (0.48) | PPARAPPARGPPARDCYP4F2CYP4A11 | |
| SCHEMBL6508843 | 0.83 | PPARA (0.48) | PPARAPPARGPPARDBCL9CTNNB1 | |
| SCHEMBL6512670 | 0.80 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL6509795 | 0.80 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL6510004 | 0.80 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL6511563 | 0.80 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL6510857 | 0.80 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL6511113 | 0.78 | PPARA (0.51) | PPARAPPARGPPARD | |
| SCHEMBL6531406 | 0.78 | PPARA (0.48) | PPARAPPARGPPARDBCL9CTNNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005080354-A1 | 1,2,4-TRIAZINES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN HUMAN THERAPEUTICS | PIERRE FABRE MEDICAMENT (FR) | 2005-09-01 | — | — | WO | claimed |